In AI We Trust? The Future of Genomic Medicine

As our ability to sequence genomes has skyrocketed, allowing us to churn out A's, C's, G's, and T's at breakneck speed, our capacity to decipher the sequences has not kept up. This issue was discussed at a recent meeting organized by Advances in Genome Biology and Technology. "We have well exceeded our ability as humans to deal with data," said Eric Topol, MD, founder and director of the Scripps Research Translational Institute, professor, molecular medicine, and executive vice president of Scripps Research. "We need help from machines." To have high-performance medicine, he asserted, "we need high-performance computing."